| 000 | 01738 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516015006.0 | ||
| 264 | 0 | _c20110624 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1347-8648 | ||
| 024 | 7 |
_a10.1254/jphs.10173fp _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsukumo, Yukihito | |
| 245 | 0 | 0 |
_aGabapentin and pregabalin inhibit the itch-associated response induced by the repeated application of oxazolone in mice. _h[electronic resource] |
| 260 |
_bJournal of pharmacological sciences _c2011 |
||
| 300 |
_a27-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmines _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCalcium Channels |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Eruptions _xcomplications |
| 650 | 0 | 4 | _aGabapentin |
| 650 | 0 | 4 |
_aGanglia, Spinal _xmetabolism |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aOxazolone |
| 650 | 0 | 4 | _aPregabalin |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 |
_aUrticaria _xdrug therapy |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xadministration & dosage |
| 700 | 1 | _aMatsumoto, Yuichi | |
| 700 | 1 | _aMiura, Hiroko | |
| 700 | 1 | _aYano, Hiroshi | |
| 700 | 1 | _aManabe, Haruhiko | |
| 773 | 0 |
_tJournal of pharmacological sciences _gvol. 115 _gno. 1 _gp. 27-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1254/jphs.10173fp _zAvailable from publisher's website |
| 999 |
_c20446547 _d20446547 |
||